₹543.25
+1.74%NSE close, 16 Nov 2026
+43.85%
Sahajanand Medical Technologies is a small cap company, listed on NSE under the symbol SMT. At ₹543.25 a share, the market values the whole company at ₹5,522 crore.
Promoters hold 36.20% of the shares. Foreign institutions hold 35.10%, and domestic institutions, mutual funds among them, 11.83%.
₹ crore. Consolidated figures.
| Line | Sep 2026 |
|---|---|
| Sales | 373 |
| Expenses | 308 |
| Operating profit | 65.6 |
| Operating margin | 17.6% |
| Other income | 2.2 |
| Interest | 6.8 |
| Depreciation | 20.9 |
| Profit before tax | 40.1 |
| Tax | 13.6 |
| Net profit | 25.8 |
| EPS (₹) | 2.63 |
Transcript of Earnings Call for Q2 & H1FY27 Financial Results held on Thursday, November 05, 2026
Publication of Unaudited Financial Results for the quarter and half year ended September 30, 2026 in Newspapers
Change in Auditors of the company.
Approval of Board of Directors of the Company for investment by wholly owned subsidiary company in SNP Medical Corp.
₹ crore, financial years to March.
Not filed yet.
₹ crore, at each year's end and the latest half year.
| Line | Sep 2026 |
|---|---|
| Shareholders’ equity | 737 |
| Borrowings | 302 |
| Total liabilities | 581 |
| Fixed assets | 278 |
| Investments | 30.0 |
| Cash and equivalents | 78.2 |
| Total assets | 1,326 |
₹ crore, by financial year, and the latest half year.
| Line | 6M to Sep 2026 |
|---|---|
| From operations | 47.4 |
| From investing | −39.8 |
| From financing | −3.4 |
| Spent on fixed assets | −42.1 |
| Free cash flow | 5.2 |
Margins, returns, debt, tax and cash.
Not filed yet.
The financial results for the period ended September 30, 2026.
Schedule of Earnings Conference call to discuss the Q2 & H1FY27 financial results to be held on Thursday, November 05, 2026 at 06:30 p.m. (IST).
Summons received under section 70 of Central Goods and Service tax Act.
Intimation under Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
Disclosure under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.